ArticleHuman vaccines & immunotherapeutics2022

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study.

Nasamon Wanlapakorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.